Company

Yet again a successful business year for EUROIMMUN

2015 was yet again a very satisfying year for EUROIMMUN, as announced at the Annual Meeting of Shareholders on 8 July 2016. This year, around 750 shareholders assisted the meeting, which is a new record. With an increase of 17.5%, the Group turnover exceeded the threshold of 200 million euros for the first time (amounting

Company

A promising scientific partnership: EUROIMMUN and the University of Zittau/Görlitz

A few days ago the “Sächsische Aufbaubank”, the central development agency of the Free State of Saxony, granted the funding of the joint research project EUROPure of EUROIMMUN and the University of Applied Sciences of Zittau/Görlitz. The project aims at the joint development of a robust technology platform permitting cost-efficient and resource-friendly preparation of proteins

Company

Another successful year for EUROIMMUN

2014 was once again a successful business year for EUROIMMUN Medizinische Labordiagnostika AG, as the supervisory board and the board of directors of the company could report to the 260 shareholders at the General Meeting on 10th July 2015. The company’s turnover increased by 24.4 % compared to the previous year to over 134.1 million

Scroll to Top